An analysis of past research conducted by the Salt Lake City-based University of Utah Health John A. Moran Eye Center found cause for further testing to determine if cataracts might someday be ...

The planned Phase 3 study is a randomized, placebo-controlled, double-masked, multicenter clinical trial designed to evaluate the safety and efficacy of TRIESENCE in patients undergoing cataract ...

Please provide your email address to receive an email when new articles are posted on . A novel preservative-free betamethasone eye drop formulation showed efficacy in preventing inflammation and pain ...

FDA IND clearance enables a phase 3 program evaluating TRIESENCE for postoperative ocular inflammation and pain following cataract surgery, aiming to broaden on-label use beyond current intraocular ...

Please provide your email address to receive an email when new articles are posted on . Dropless or reduced drop cataract surgery can improve patient compliance, reduce costs, reduce ocular surface ...

Credit: Getty Images. OCS-01 is a novel, high concentration (15mg/mL), topical formulation of dexamethasone. Once-daily administration of an investigational corticosteroid eye drop (OCS-01) was found ...

Santen EMEA and NTC are delighted to announce that the results of their phase III clinical study, LEADER7, have been published in Eye. The study demonstrated for the ...

Hormonal shifts, lifestyle habits, and age-related changes can significantly impact women's eye health. Experts explain why regular eye check-ups and preventive care are essential at every stage of ...

New minimally invasive glaucoma treatments, including stents placed during cataract surgery and long-acting eye implants, are now available in Cape May County, reducing reliance on daily eye drops.